BioCryst Pharmaceuticals, Inc. (BCRX)
9.67
+0.26
(+2.76%)
USD |
NASDAQ |
Apr 14, 16:00
9.66
-0.01
(-0.10%)
After-Hours: 20:00
BioCryst Pharmaceuticals Cash from Investing (TTM) : -13.69M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Anika Therapeutics, Inc. | -0.401M |
| Lantheus Holdings, Inc. | -627.17M |
| Revolution Medicines, Inc. | 118.06M |
| Plus Therapeutics, Inc. | -0.854M |
| BioStem Technologies, Inc. | -2.102M |